Otto‐Michael Lesch

1.1k total citations
30 papers, 710 citations indexed

About

Otto‐Michael Lesch is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Otto‐Michael Lesch has authored 30 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 5 papers in Pathology and Forensic Medicine and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Otto‐Michael Lesch's work include Alcohol Consumption and Health Effects (5 papers), Alcoholism and Thiamine Deficiency (4 papers) and Circadian rhythm and melatonin (3 papers). Otto‐Michael Lesch is often cited by papers focused on Alcohol Consumption and Health Effects (5 papers), Alcoholism and Thiamine Deficiency (4 papers) and Circadian rhythm and melatonin (3 papers). Otto‐Michael Lesch collaborates with scholars based in Austria, Germany and United States. Otto‐Michael Lesch's co-authors include H. Walter, A. Nimmerrichter, H. Oberbauer, WW Fleischhacker, A. Potgieter, Felix Fischer, Anne Whitworth, Henrik Walter, M. Musalek and Karl Mann and has published in prestigious journals such as The Lancet, Journal of Affective Disorders and Progress in Neuro-Psychopharmacology and Biological Psychiatry.

In The Last Decade

Otto‐Michael Lesch

30 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Otto‐Michael Lesch Austria 13 226 212 165 141 140 30 710
E. Tempesta Italy 18 342 1.5× 233 1.1× 104 0.6× 157 1.1× 120 0.9× 49 1.1k
Alexander Diehl Germany 15 255 1.1× 291 1.4× 99 0.6× 138 1.0× 85 0.6× 33 835
Markus Banger Germany 16 134 0.6× 101 0.5× 130 0.8× 160 1.1× 89 0.6× 43 691
L. Branchey United States 18 165 0.7× 177 0.8× 133 0.8× 121 0.9× 79 0.6× 25 821
Raymond F. Anton United States 7 226 1.0× 394 1.9× 103 0.6× 124 0.9× 62 0.4× 9 802
Robert Malcolm United States 15 464 2.1× 226 1.1× 257 1.6× 195 1.4× 141 1.0× 24 1.4k
P.J. Geerlings Netherlands 10 234 1.0× 279 1.3× 86 0.5× 101 0.7× 69 0.5× 12 708
A.L.C. Pottash United States 20 336 1.5× 130 0.6× 258 1.6× 63 0.4× 213 1.5× 53 1.3k
Carolina L. Haass‐Koffler United States 18 348 1.5× 276 1.3× 51 0.3× 80 0.6× 92 0.7× 55 1.0k
A.M. Burakov Russia 12 317 1.4× 275 1.3× 107 0.6× 129 0.9× 240 1.7× 21 845

Countries citing papers authored by Otto‐Michael Lesch

Since Specialization
Citations

This map shows the geographic impact of Otto‐Michael Lesch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Otto‐Michael Lesch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otto‐Michael Lesch more than expected).

Fields of papers citing papers by Otto‐Michael Lesch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Otto‐Michael Lesch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Otto‐Michael Lesch. The network helps show where Otto‐Michael Lesch may publish in the future.

Co-authorship network of co-authors of Otto‐Michael Lesch

This figure shows the co-authorship network connecting the top 25 collaborators of Otto‐Michael Lesch. A scholar is included among the top collaborators of Otto‐Michael Lesch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Otto‐Michael Lesch. Otto‐Michael Lesch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grünberger, J, Benjamin Vyssoki, József Constantin Széles, et al.. (2023). Pupillary response to percutaneous auricular vagus nerve stimulation in alcohol withdrawal syndrome: A pilot trial. Alcohol. 114. 61–68. 3 indexed citations
2.
Brink, Wim van den, Giovanni Addolorato, Henri‐Jean Aubin, et al.. (2018). Efficacy and safety of sodium oxybate in alcohol‐dependent patients with a very high drinking risk level. Addiction Biology. 23(4). 969–986. 44 indexed citations
3.
Unseld, Matthias, Ulrich S. Tran, Paul L. Plener, et al.. (2012). The concept of temperament in psychoactive substance use among college students. Journal of Affective Disorders. 141(2-3). 324–330. 32 indexed citations
4.
Vyssoki, Benjamin, Matthäus Willeit, Victor Blüml, et al.. (2011). Inpatient treatment of major depression in Austria between 1989 and 2009: Impact of downsizing of psychiatric hospitals on admissions, suicide rates and outpatient psychiatric services. Journal of Affective Disorders. 133(1-2). 93–96. 11 indexed citations
5.
Höfer, Peter, Bonni Syeda, Jutta Bergler‐Klein, et al.. (2011). Amino-Terminal Pro-B-Type Brain Natriuretic Peptide: Screening for Cardiovascular Disease in the Setting of Alcoholism. Alcohol and Alcoholism. 46(3). 247–252. 8 indexed citations
6.
Soyka, Michael, Gabriele Koller, Peggy Schmidt, et al.. (2008). Cannabinoid Receptor 1 Blocker Rimonabant (SR 141716) for Treatment of Alcohol Dependence. Journal of Clinical Psychopharmacology. 28(3). 317–324. 85 indexed citations
7.
Ruhrmann, Stephan, et al.. (2007). Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptoms. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31(5). 1012–1022. 20 indexed citations
8.
Philipp, Michael, Thomas Gläser, Manfred Beneke, et al.. (2003). Flupenthixol versus Risperidone: Subjective Quality of Life as an Important Factor for Compliance in Chronic Schizophrenic Patients. Neuropsychobiology. 47(1). 37–46. 21 indexed citations
9.
Ramskogler, Katrin, et al.. (2001). [Possible interaction between ethanol and drugs and their significance for drug therapy in the elderly].. PubMed. 113(10). 363–70. 5 indexed citations
10.
Mußhoff, Frank, et al.. (1996). Formaldehyde-derived tetrahydroisoquinolines and tetrahydro-β-carbolines in human urine. Journal of Chromatography B Biomedical Sciences and Applications. 683(2). 163–176. 18 indexed citations
11.
Sperling, Wolfgang & Otto‐Michael Lesch. (1996). The reduction of alcohol consumption with novel pharmacological intervention. European Psychiatry. 11(5). 217–226. 3 indexed citations
12.
Whitworth, Anne, H. Oberbauer, WW Fleischhacker, et al.. (1996). Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. The Lancet. 347(9013). 1438–1442. 234 indexed citations
13.
Lesch, Otto‐Michael. (1992). TOWARDS A STANDARDISATION FOR THE METHODOLOGY IN TREATMENT RESEARCH OF ALCOHOL ABUSE AND ALCOHOLISM. Clinical Neuropharmacology. 15. 307A–308A. 2 indexed citations
14.
15.
Musalek, M., I. Podreka, E. Suess, et al.. (1988). Neurophysiological Aspects of Auditory Hallucinations. Psychopathology. 21(6). 275–280. 15 indexed citations
16.
Barz, J., et al.. (1988). Investigations on methanol kinetics in alcoholics.. PubMed. 25(3). 163–71. 8 indexed citations
17.
Musalek, M., Otto‐Michael Lesch, & William F. Kieffer. (1987). Dysphoric States in the Course of Manic-Depressive Illness. Psychopathology. 20(2). 107–114. 6 indexed citations
18.
Lesch, Otto‐Michael, et al.. (1986). MEDIKAMENTENGEBRAUCH UND VERKEHRSSICHERHEIT. (EINE FUER OESTERREICH REPRAESENTATIVE STUDIE).. 31(6). 1 indexed citations
19.
Dietzel, Margot, et al.. (1986). Light Treatment in Depressive Illness. European Neurology. 25(2). 93–103. 49 indexed citations
20.
Berner, P., et al.. (1986). Alcohol and Depression. Psychopathology. 19(2). 177–183. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Tempesta Breakdown of academic impact, for papers by Alexander Diehl Breakdown of academic impact, for papers by Markus Banger Breakdown of academic impact, for papers by L. Branchey Breakdown of academic impact, for papers by Raymond F. Anton Breakdown of academic impact, for papers by Robert Malcolm Breakdown of academic impact, for papers by P.J. Geerlings Breakdown of academic impact, for papers by A.L.C. Pottash Breakdown of academic impact, for papers by Carolina L. Haass‐Koffler Breakdown of academic impact, for papers by A.M. Burakov
Rankless by CCL
2026